| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |